title: [In vitro dynamics of parathyroid hormone secretion regulated by calcium and effects on the cell cycle: parathyroid hyperplasia versus adenoma].
abstract: OBJECTIVE
  To compare the dynamics of calcium-regulated PTH secretion in vitro from adenomatous versus hyperplastic glands and to investigate the relationship between the parathyroid cell cycle and the calcium-regulated PTH secretion in these glands.
  
  
  METHODS
  A total of 31 parathyroid glands (8 adenomatous and 23 hyperplastic) from 8 patients with primary hyperparathyroidism and 7 with secondary hyperparathyroidism respectively were studied. For the evaluation of calcium-regulated PTH secretion, small parathyroid pieces of 1 mm were sequentially transferred to wells with varying Ca concentrations: 0.4, 0.6, 0.8, 1, 1.25 and 1.35 or 1.5 mM. PTH concentrations were determined in the medium. For the parathyroid cell cycle studies, parathyroid cells were isolated without the use of enzymes and cell cycle was analyzed using the method described by Vindelov. The nuclei were acquired by flow cytometer and analyzed using the CELLFIT software.
  
  
  RESULTS
  In parathyroid tissues from hyperplastic glands, the increase in extracellular calcium produced a decrease in PTH secretion which was apparent with a calcium level as low as 0.8 mM and the maximal inhibition of PTH secretion was obtained with a calcium of 1.25 mM, by the contrary, adenomatous glands required a calcium of 1.2 mM to produce a minimal decrease in PTH secretion. In hyperplastic parathyroid glands but not in parathyroid adenomas there was a significant correlation between the percentage of cells in G0/G1 phase with the set point (r = 0.914; P < 0.005) and the basal serum Ca (r = 0.862; P < 0.02).
  
  
  CONCLUSIONS
  The control of the extracellular calcium-PTH release in vitro is less sensitive in parathyroid adenomas than hyperplasic parathyroid glands. In parathyroid hyperplasia the cell proliferation may be regulated by the extracellular calcium concentration (higher calcemia less proliferation).
authors.affiliation: Unidad de Trasplante Renal, Hospital Clínic, Barcelona. carlosed36@gmail.com
authors.forename: C E
authors.initials: CE
authors.lastname: Durán
authors.forename: J V
authors.initials: JV
authors.lastname: Torregrosa
authors.forename: A
authors.initials: A
authors.lastname: Canalejo
authors.forename: Y
authors.initials: Y
authors.lastname: Almadén
authors.forename: J M
authors.initials: JM
authors.lastname: Campistol
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez Portillo
mesh_terms: D000236:Adenoma / Q000378:metabolism*; D002118:Calcium / Q000502:physiology*; D002453:Cell Cycle / Q000502:physiology*; D005260:Female; D006801:Humans; D006965:Hyperplasia; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010280:Parathyroid Glands / Q000378:metabolism* / Q000473:pathology*; D010281:Parathyroid Hormone / Q000378:metabolism*; D010282:Parathyroid Neoplasms / Q000378:metabolism*
chemical_list: D010281:Parathyroid Hormone; D002118:Calcium